Citadel Advisors’s Perspective Therapeutics CATX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $153K | Sell |
|
|||||
|
2025
Q1 | $1.08M | Buy |
|
|||||
|
2024
Q4 | $685K | Buy |
|
|||||
|
2024
Q3 | $161K | Sell |
|
|||||
|
2024
Q2 | $5.74M | Sell |
|
|||||
|
2024
Q1 | $14.6M | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $111K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $75.5K | Buy |
|
|||||
|
2022
Q3 | $6K | Sell |
|
|||||
|
2022
Q2 | $13K | Sell |
|
|||||
|
2022
Q1 | $46K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $7K | Sell |
|
|||||
|
2021
Q2 | $41K | Sell |
|
|||||
|
2021
Q1 | $134K | Buy |
|
|||||
|
2020
Q4 | $43K | Buy |
|
|||||
|
2020
Q3 | $35K | Sell |
|
|||||
|
2020
Q2 | $42K | Buy |
|
|||||
|
2020
Q1 | $12K | Sell |
|
|||||
|
2019
Q4 | $23K | Sell |
|
|||||
|
2019
Q3 | $20K | Buy |
|
|||||
|
2019
Q2 | $16K | Sell |
|
|||||
|
2019
Q1 | $17K | Buy |
|
|||||
|
2018
Q4 | $7K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $57K | Buy |
|
|||||
|
2017
Q4 | $38K | Buy |
|
|||||
|
2017
Q3 | $15K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $9K | Sell |
|
|||||
|
2016
Q4 | $35K | Buy |
|
|||||
|
2016
Q3 | $24K | Sell |
|
|||||
|
2016
Q2 | $30K | Sell |
|
|||||
|
2016
Q1 | $94K | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $22K | Buy |
|
|||||
|
2015
Q1 | – | Sell |
|
|||||
|
2014
Q4 | $45K | Buy |
|
|||||
|
2014
Q3 | – | Sell |
|
|||||
|
2014
Q2 | $197K | Buy |
|
|||||
|
2014
Q1 | – | Sell |
|
|||||
|
2013
Q4 | $18K | Buy |
|